Cyclopentadienylindenylzirconium dichloride - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 10824

<< First< Prev

Page of 542

Next >Last >>

The following term was not found in PMC: Cyclopentadienylindenylzirconium.

Select item 66454971.

Synthesis and Structural Analysis of (Imido)vanadium Dichloride Complexes Containing 2-(2′-Benz-imidazolyl)pyridine Ligands: Effect of Al Cocatalyst for Efficient Ethylene (Co)polymerization

Kotohiro Nomura, Mari Oshima, Takato Mitsudome, Hitoshi Harakawa, Peng Hao, Ken Tsutsumi, Go Nagai, Toshiaki Ina, Hikaru Takaya, Wen-Hua Sun, Seiji Yamazoe

ACS Omega. 2017 Dec 31; 2(12): 8660–8673. Published online 2017 Dec 6. doi: 10.1021/acsomega.7b01225

PMCID:: PMC6645497

Abstract Article PDF–1.9M

Select item 68548292.

XAS Analysis of Reactions of (Arylimido)vanadium(V) Dichloride Complexes Containing Anionic NHC That Contains a Weakly Coordinating B(C₆F₅)₃ Moiety (WCA-NHC) or Phenoxide Ligands with Al Alkyls: A Potential Ethylene Polymerization Catalyst with WCA-NHC Ligands

Kotohiro Nomura, Go Nagai, Itsuki Izawa, Takato Mitsudome, Matthias Tamm, Seiji Yamazoe

ACS Omega. 2019 Nov 12; 4(20): 18833–18845. Published online 2019 Oct 31. doi: 10.1021/acsomega.9b02828

PMCID:: PMC6854829

Abstract Article PDF–3.5M

Select item 61350753.

Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?

Isis Gayed, Vivian Salama, Lydia Dawood, Steven Canfield, David Wan, Chunyan Cai, Usha Joseph, Robert Amato

Cancer Manag Res. 2018; 10: 3317–3324. Published online 2018 Sep 7. doi: 10.2147/CMAR.S166218

PMCID:: PMC6135075

Abstract Article PDF–1.2M

Select item 84671834.

Mass Spectrometric Evaluation of β-Cyclodextrins as Potential Hosts for Titanocene Dichloride

Pia S. Bruni, Stefan Schürch

Int J Mol Sci. 2021 Sep; 22(18): 9789. Published online 2021 Sep 10. doi: 10.3390/ijms22189789

PMCID:: PMC8467183

Abstract Article PDF–1.7M

Select item 61750455.

The potential of ²²³Ra and ¹⁸F-Fluoride imaging to predict bone lesion response to treatment with ²²³Ra-Dichloride in castration resistant prostate cancer

Iain Murray, Sarah J. Chittenden, Ana M. Denis-Bacelar, Cecilia Hindorf, Christopher C. Parker, Sue Chua, Glenn D. Flux

Eur J Nucl Med Mol Imaging. Author manuscript; available in PMC 2018 Oct 8.

Published in final edited form as: Eur J Nucl Med Mol Imaging. 2017 Oct; 44(11): 1832–1844. Published online 2017 Jun 13. doi: 10.1007/s00259-017-3744-y

PMCID:: PMC6175045

Abstract Article PDF–1.5M

Select item 56087846.

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

Hiroji Uemura, Hirotsugu Uemura, Nobuaki Matsubara, Seigo Kinuya, Makoto Hosono, Yoko Yajima, Toshihiko Doi

Int J Clin Oncol. 2017; 22(5): 954–963. Published online 2017 May 6. doi: 10.1007/s10147-017-1130-1

PMCID:: PMC5608784

Abstract Article PDF–470K

Select item 65720367.

Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data

Theodoros G. Soldatos, Ioannis Iakovou, Christos Sachpekidis

Medicina (Kaunas) 2019 May; 55(5): 149. Published online 2019 May 16. doi: 10.3390/medicina55050149

PMCID:: PMC6572036

Abstract Article PDF–312K

Select item 62088108.

²²³Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice

Sabina Dizdarevic, Maryam Jessop, Patrick Begley, Sean Main, Angus Robinson

Eur J Nucl Med Mol Imaging. 2018; 45(13): 2264–2273. Published online 2018 Jul 11. doi: 10.1007/s00259-018-4083-3

PMCID:: PMC6208810

Abstract Article PDF–1.0M

Select item 72684779.

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Hamza Hasan, Matthew P. Deek, Ryan Phillips, Robert F. Hobbs, Reem Malek, Noura Radwan, Ana P. Kiess, Shirl Dipasquale, James Huang, Terry Caldwell, Jessica Leitzel, Danielle Wendler, Hao Wang, Elizabeth Thompson, Jonathan Powell, Sara Dudley, Curtiland Deville, Stephen C. Greco, Daniel Y. Song, Theodore L. DeWeese, Michael A. Gorin, Steven P. Rowe, Sam Denmeade, Mark Markowski, Emmanuel S. Antonarakis, Michael A. Carducci, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Channing J. Paller, Phuoc T. Tran

BMC Cancer. 2020; 20: 492. Published online 2020 Jun 1. doi: 10.1186/s12885-020-07000-2

PMCID:: PMC7268477

Abstract Article PDF–2.5M

Select item 416898610.

Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone

Amol Takalkar, Scott Adams, Vivek Subbiah

Exp Hematol Oncol. 2014; 3: 23. Published online 2014 Sep 8. doi: 10.1186/2162-3619-3-23

PMCID:: PMC4168986

Abstract Article PDF–1.3M

Select item 766673411.

Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer

Kohei Hashimoto, Yasuhide Miyoshi, Tetsuya Shindo, Masakazu Hori, Yasumasa Tsuboi, Ko Kobayashi, Fumimasa Fukuta, Toshiaki Tanaka, Shintaro Miyamoto, Takeshi Maehana, Manabu Okada, Naotaka Nishiyama, Masahiro Yanase, Ryuichi Kato, Hiroshi Hotta, Yasuharu Kunishima, Atsushi Takahashi, Shiro Hinotsu, Koh‐ichi Sakata, Hiroshi Kitamura, Hiroji Uemura, Naoya Masumori

Cancer Med. 2020 Nov; 9(22): 8579–8588. Published online 2020 Sep 22. doi: 10.1002/cam4.3459

PMCID:: PMC7666734

Abstract Article PDF–693K

Select item 929936512.

Methods of a New Chronic Pancreatitis and Spontaneous Pancreatic Cancer Mouse Model Using Retrograde Pancreatic Duct Injection of Dibutyltin Dichloride

Deyu Zhang, Wanshun Li, Meiqi Wang, Hua Yin, Chuanchao Xia, Keliang Li, Haojie Huang

Front Oncol. 2022; 12: 947133. Published online 2022 Jul 6. doi: 10.3389/fonc.2022.947133

PMCID:: PMC9299365

Abstract Article PDF–7.1M

Select item 996432313.

New Titanocene (IV) Dicarboxylates with Potential Cytotoxicity: Synthesis, Structure, Stability and Electrochemistry

Dmitry A. Guk, Karina R. Gibadullina, Roman O. Burlutskiy, Kirill G. Pavlov, Anna A. Moiseeva, Viktor A. Tafeenko, Konstantin A. Lyssenko, Erik R. Gandalipov, Alexander A. Shtil, Elena K. Beloglazkina

Int J Mol Sci. 2023 Feb; 24(4): 3340. Published online 2023 Feb 7. doi: 10.3390/ijms24043340

PMCID:: PMC9964323

Abstract Article PDF–2.6M

Select item 883361314.

Safety and Efficacy of ¹⁷⁷Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing ²²³Radium-Dichloride

Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, Nicolai Mader, Maximilian Chaurasia, Karen Davis, Jennifer Wichert, Felix K. H. Chun, Nikolaos Tselis, Christian Happel, Frank Grünwald, Amir Sabet

Cancers (Basel) 2022 Feb; 14(3): 557. Published online 2022 Jan 22. doi: 10.3390/cancers14030557

PMCID:: PMC8833613

Abstract Article PDF–1.1M

Select item 409091915.

MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy

Tze Yee Lim, R Jason Stafford, Rajat J Kudchadker, Madhuri Sankaranarayanapillai, Geoffrey Ibbott, Arvind Rao, Karen S Martirosyan, Steven J Frank

Phys Med Biol. Author manuscript; available in PMC 2015 May 21.

Published in final edited form as: Phys Med Biol. 2014 May 21; 59(10): 2505–2516. Published online 2014 Apr 28. doi: 10.1088/0031-9155/59/10/2505

PMCID:: PMC4090919

Abstract Article PDF–1.4M

Select item 599577316.

Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals

Joon Young Choi

Nucl Med Mol Imaging. 2018 Jun; 52(3): 200–207. Published online 2018 Jan 12. doi: 10.1007/s13139-017-0509-2

PMCID:: PMC5995773

Abstract Article PDF–535K

Select item 335110617.

Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives

Enrique Meléndez

J Organomet Chem. Author manuscript; available in PMC 2013 Jun 1.

Published in final edited form as: J Organomet Chem. 2012 Jun 1; 706-707: 4–12. Published online 2012 Feb 6. doi: 10.1016/j.jorganchem.2012.02.006

PMCID:: PMC3351106

Abstract Article PDF–1.1M

Select item 403090118.

Effect of Electrical Conductivity Through the Bulk Doping of the Product of Titanocene Dichloride and 2-Nitro-1,4-phenylenediamine

Charles E. Carraher, Jr., Amitabh J. Battin, Michael R. Roner

J Funct Biomater. 2011 Mar; 2(1): 18–30. Published online 2011 Mar 17. doi: 10.3390/jfb2010018

PMCID:: PMC4030901

Abstract Article PDF–198K

Select item 441209419.

Synthesis and Biological Evaluation of Achiral Indole-Substituted Titanocene Dichloride Derivatives

Anthony Deally, Frauke Hackenberg, Grainne Lally, Matthias Tacke

Int J Med Chem. 2012; 2012: 905981. Published online 2012 Jun 12. doi: 10.1155/2012/905981

PMCID:: PMC4412094

Abstract Article PDF–1.5M

Select item 477991920.

Pathophysiology of chronic pancreatitis induced by dibutyltin dichloride joint ethanol in mice

Hong Zhang, Bin Liu, Xiao-Fan Xu, Ting-Ting Jiang, Xiao-Qin Zhang, Ying-Li Shi, Yu Chen, Fang Liu, Jie Gu, Lin-Jia Zhu, Nan Wu

World J Gastroenterol. 2016 Mar 14; 22(10): 2960–2970. Published online 2016 Mar 14. doi: 10.3748/wjg.v22.i10.2960

PMCID:: PMC4779919

Abstract Article PDF–2.5M

<< First< Prev

Page of 542

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for Cyclopentadienylindenylzirconium dichloride

Figure 3

Structures of thiol derivatives of molybdenocene dichloride.

Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives

J Organomet Chem. ;706-707:4-12.
Figure 2

Imaging study with ¹⁸F-FDG PET/CT. A: ¹⁸F-FDG PET/CT imaging studies at baseline, before administration of radium-223 (Ra-223) dichloride, B: ⁸F-FDG PET/CT imaging studies after 2 treatments with Ra-223 dichloride but before the third treatment.

Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone

Exp Hematol Oncol. 2014;3:23-23.
Figure 3

Imaging study with ¹⁸Na-F Bone PET/CT. A: ¹⁸NA-F bone PET/CT imaging studies at baseline, before administration of radium-223 (Ra-223) dichloride, B: ⁸NA-F bone PET/CT imaging studies after 2 treatments with Ra-223 dichloride but before the third treatment.

Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone

Exp Hematol Oncol. 2014;3:23-23.
Figure 1

Decay of radium-223 dichloride (Ra-223).

Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride

Int J Urol Nurs. 2015 Mar;9(1):3-13.